May 2015

May 2015

Register by June 15 for Super Early Bird Rates for the 2015 Rejuvenation Biotechnology Conference

 

Where: Hyatt Regency San Francisco Airport, Burlingame, CA

When: August 19 - 21, 2015

To Register: http://sens.org/rb2015

 

Reminder: Poster Abstracts for the RB2015 Poster Session are due JUNE 1
 
The Rejuvenation Biotechnology Conference Poster Session is open for abstract submissions until June 1st, 2015. No late submissions will be accepted, so make sure your entry is in on time.
 
For details and requirements, go to www.sens.org/rb2015/poster.
 
Participants will present their work during two evening poster sessions at the conference. Abstracts are due June 1st. Primary authors of accepted abstracts will be notified on July 1, 2015.
 
NEW THIS YEAR: SENS Research Foundation is offering RB2015 Travel Awards to selected student and postdoctoral fellow poster presenters. SRF will reimburse up to $2000 of registration, travel, and hotel costs for each award winner. Prize recipients will present their research during the RB2015 Poster Session. Note that registration includes meals provided during the conference. Travel award winners will be notified by July 15th. To learn more, visit www.sens.org/rb2015/poster.

New Confirmed Speakers for RB2015 Conference

 

We are pleased to announce that twelve more expert speakers have joined the roster for our second upcoming Rejuvenation Biotechnologies conference:

  • Marc Better, Vice President, Product Sciences, Kite Pharma
  • David DiGiusto, Executive Director/Senior Academic Researcher, Stanford Hospital and Clinics/Stanford University
  • Rita Effros, Professor of Pathology & Laboratory Medicine, University of California, Los Angeles
  • Jay Jerome, Associate Professor and Graduate Program Director, Vanderbilt University Medical Center
  • Brian Kennedy, President and CEO, Buck Institute for Research on Aging
  • Jane Lebkowski, President of R&D, Asterias Biotherapeutics Inc.
  • Linda Marbán, CEO, Capricor Therapeutics
  • Cathy Prescott, Director, Biolatris Ltd.
  • Brock Reeve, Executive Director, Harvard Stem Cell Institute
  • Jerry Shay, Vice Chairman, Department of Cell Biology, The University of Texas Southwestern Medical Center at Dallas
  • Evan Snyder, Director, Center for Stem Cell and Regenerative Medicine/Core Facility, Sanford-Burnham Medical Research Institute
  • John Trojanowski, Professor of Geriatric Medicine and Gerontology, University of Pennsylvania

Watch your inbox for more important conference announcements, including this year's keynote speakers, and make sure and register today.

BBC World News - Horizons to feature SRF's Mitochondrial Mutations project

 

 

SRF's Mitochondrial Mutations researchers recently got an opportunity to share some of their work with the BBC World News Horizons team. Horizons is a new series that seeks to explore the various ways technology could change our lives in the decades ahead.

 

Mark your calendars and make sure to visit www.bbc.com/horizonsbusiness to view Episode 3 - Extending Lives, which will air on the following dates at the indicated times:

 

May 23rd - 01:30, 08:30 (GMT)

May 24th - 14:30, 20:30 (GMT)

 

 

For more interaction and opportunity to discuss the show, you can also follow us on Twitter and join the conversation on Facebook.

SRF Education Video Spotlight: 2014 Harvard Stem Cell Institute, Oxford, and University College London Summer Scholars

 

Over the summer of 2014, SENS Research Foundation partnered with the Centre for the Advancement of Sustainable Medical Innovation (CASMI), an organization focused on developing new models for medical innovation, to sponsor research by four students: Rebecca Jones, James Smith, Rahul Rekhi, and Sheri Zada. This video highlights the experiences they had at the Harvard Stem Cell Institute, the University of Oxford, and University College London.

 

 

Watch future newsletters for more SRF Education program highlights and introductions to our 2015 Summer Scholars as they begin their assignments.

In the Media

 

The Joe Rogan Experience

Podcast #638

 

Listen to SRF's Aubrey de Grey chat with host Joe Rogan on the current state of aging research and why the tendency to treat age-associated health problems in isolation is bound to fail, whereas a comprehensive damage-repair approach has the best chance of success.

 

London Real

Aubrey de Grey - How To Live Forever

 

In this interview with Brian Rose of London Real, Aubrey addresses many of the most commonly asked questions about SENS, aging, and the likely impact of rejuvenation biotechnologies on the world and the state of medicine. 

 

Upcoming Events

 

Arctic15: Exit Path Conference

May 26-27, 2015

The Cable Factory, Helsinki, Finland

SRF CSO Dr. Aubrey de Grey to speak

 

 

The Arctic15 Conference is organized by ArcticStartup, an independent technology blog that reports on digital startups and growth entrepreneurship from the Nordic and Baltic countries. This will be the fourth edition of the conference, which aims to provide exceptional coverage of the news and trends needed to support a developed entrepreneurship community in Northern Europe. 

 

 

Question of the Month #10: Rejuvenation for calcification amelioration?

 

Q: A lot of tissues, including notably the arteries, develop calcium deposits with age. Isn't this also an important kind of aging damage? Don't you need to develop a new rejuvenation biotechnology to remove it from our tissues?
 
A: To answer the question, we first need to disaggregate (no pun intended) the general category of "calcification." There are quite a few tissues that calcify to some degree in most or all aging people, and the reasons why this occurs and the nature of the structural disruption it causes are quite distinct depending on the tissue. In fact, even looking at just the arteries, there are several different kinds of "arterial calcification," including calcification connected with atherosclerotic plaque and calcification of the fibrils of elastin protein that loan the arteries their elasticity.
 
It's unlikely that all of these are true aging damage, but it's quite plausible that at least some of them are. The key question is whether each of these calcified deposits are really an intrinsically more or less irreversible change, or if like many other things that go wrong in aging they're sufficiently dependent on other, primary age-related changes that they would revert to the healthy norm if the original insult were resolved...
 

The "Question of the Month" column is your opportunity to submit your research-related queries to SRF's expert science writer Michael Rae. Please send your questions to foundation@sens.org and they may be featured in a future newsletter.

Want to help spread the word about SRF's mission?

Share our vision to Reimagine Aging on

 

   Facebook       @SENSTweet

Want your Amazon purchases to help fight age-related disease?

Shopping for Mother's Day?
If you do it on Amazon be sure to sign up for Amazon Smile and designate SENS Research Foundation.
 

 

Amazon.com will make a donation to SRF every time you buy using AmazonSmile.

Click below to sign up.

 

Please show your support for SRF's work - Donate Today.

As a 501(c)(3) public charity, SENS Research Foundation relies on your support

to continue our mission to change the way the world researches and treats age-related disease.

 

 

Visit our donate page to make your contribution.